FDA approves landmark pancreatic cancer drug that’s shown to improve survival
WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer. FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonrasib, which blocks a mutated protein that fuels tumor growth in […]
Original Source
Read the full article at Coloradopolitics →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.